The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M03 | Muscle relaxants | |
| 3 | M03B | Muscle relaxants, centrally acting agents | |
| 4 | M03BC | Ethers, chemically close to antihistamines |
| Code | Title | |
|---|---|---|
| M03BC01 | Orphenadrine (citrate) | |
| M03BC51 | Orphenadrine, combinations |
| Active Ingredient | Description | |
|---|---|---|
| Orphenadrine |
Orphenadrine, which is a congener of diphenhydramine without sharing its soporific effect, is an anti-muscarinic agent. Orphenadrine is used as the hydrochloride in the symptomatic treatment of Parkinsonism. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| BESEMAX Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| NORGESIC Tablet, uncoated | Pharmaceutical Benefits Scheme (AU) | MPI, EU: SmPC |
